Back to Investor Brief

Investor Brief · Part 2

Digital Strategy: architecture, motion, and moats

Pause is a category-creation strategy as much as a product strategy. Each pillar, stage, and moat below is tagged with current status (Shipped / Wired in prototype / Designed / Future) so investors can read plan-vs-reality at a glance. Architecture briefs link out from cards whose claims they back.

Architectural pillars

Five pillars — each one verifiable today, or honestly labeled as ahead

Wired in prototype

EHR-native, never sidecar

Pause is delivered as a SMART-on-FHIR app inside Epic and Cerner workflows. The clinician never leaves their chart. This single architectural choice is the difference between adopted product and shelfware.

Today: JupyterHealth FHIR R5 substrate is wired; the MuleSoft Process API is deployed on CloudHub 2.0 today, fronting the Phase-2 contract DataWeave with the same shape every fabric consumer (UI, agent, MCP) reads; Salesforce Agentforce is the current intake surface for the live demo. SMART-on-FHIR install package itself is on the build plan, not shipped.

JupyterHealth integration brief →
Wired in prototype

Patient-side data capture

PRO and wearable data are collected via a mobile experience the patient already uses (HealthKit / Health Connect bridge), then surfaced as a structured 'pre-read' inside the EHR — not a separate inbox.

Today: DBDP Phase 1 (FLIRT-backed RMSSD) is shipped with closed-form correctness tests. Salesforce Data Cloud Calculated Insights (Pause_HRV_RMSSD_30d, Pause_Vasomotor_Burden_30d, Pause_Sleep_Disruption_7d) are LIVE on the trailsignup tenant, surfaced in every Care Router grounding payload alongside the Phase-1 SOQL signals. JupyterHealth FHIR observations land in the federated grounding payload. The native HealthKit / Health Connect bridge + real-wearable JHE/DBDP math behind the CIs (Phase 2-bis) are still ahead.

DBDP feature engineering brief →
Shipped

Recommendation, not autopilot

Pause never takes a clinical action. It surfaces a ranked, explainable recommendation set with cited evidence and an editable narrative. The clinician remains the decision maker.

Today: Enforced by the Agent Fabric policy catalog today. The Anthropic-backed Care Router emits a recommendation (not an order); the no-clinical-autonomy policy is one of the four enforced policies on every span. Trace plane records the clinician's eventual action when it lands.

See the policy catalog live →
Future

Outcomes-anchored contracting

Every customer contract includes a measurement plan: diagnostic time, symptom resolution, HT adherence, avoidable utilization, satisfaction. We are paid in part on what we deliver.

Today: No signed customer contracts yet. The measurement plan template is drafted; PMPM + diagnostic-yield + avoidable-spend metrics are the levers on the table. Outcomes telemetry pipeline exists on the trace plane.

Wired in prototype

Build the registry, own the evidence

The de-identified outcomes registry is published, contributing to the menopause evidence base, and circling back to product as the strongest competitive moat we have.

Today: Data 360 segments + cohort comparison are the prototype substrate; Phase 2 Data Cloud Calculated Insights (HRV z-score, vasomotor burden, sleep disruption) are LIVE on the trailsignup tenant and grounding every routing call today. Registry-as-product (de-identified outcomes feed back to advisory + community) is gated on the first ~12 months of customer deployment, not yet earned.

Data 360 architecture brief →

Go-to-market motion

Four stages — current stage made explicit

We are pre-design-partner. The investor brief and the working prototype are the artifacts of the Year-0-minus-one stage; first design-partner conversations are the immediate next milestone.

Future

Year 0 — design partners

3-5 forward-leaning IDNs and 1 value-based payer. Free or deeply discounted. Mutual goal: ship-quality clinical evidence and case studies. Co-author publications and conference talks.

Today: Pre-design-partner stage. Investor brief + working prototype exist; first design-partner conversations are the next milestone.

Future

Year 1 — paid pilots into ARR

Convert design partners to paid contracts. Land 3-5 new IDNs at $250-500k ACV. Begin payer pilots with PMPM structure. ARR target: $2-4M.

Today: Gated on Year 0 design-partner traction.

Future

Year 2 — peer expansion

Lean on customer references and clinical advisory network. Expand within multi-system IDNs (single hospital → enterprise). Launch employer-paid carve-out via payer partners. ARR target: $10-15M.

Today: Gated on Year 1 paid-pilot conversion.

Future

Year 3 — platform extensions

Adjacent vertical: bone health, cardiometabolic risk, sexual / pelvic health for midlife women. Continue compounding outcomes data. ARR target: $30-45M.

Today: Gated on Year 2 expansion footprint + outcomes registry density.

Competitive moats

Six moats — each compounding over deployment time

Designed

Workflow integration depth

Each Epic/Cerner deployment takes 60-120 days and meaningful clinician trust. Once installed, switching cost is high. Eventually, Pause becomes 'the way menopause care is done here.'

Today: Estimate based on industry deployment timelines for SMART-on-FHIR + Epic/Cerner App Orchard installs. No live deployment time observed yet.

JupyterHealth integration brief →
Wired in prototype

Outcomes registry

Continuous accumulation of structured outcomes data tied to specific recommendations. After 18 months of customer deployment, the registry is unreplicable by a new entrant.

Today: Trace plane records inputs/outputs/model per recommendation today. Registry as a customer-facing product is gated on customer-deployment time.

Agent Fabric brief →
Designed

Clinical advisory network

A who's-who of MSCP-credentialed and NAMS-affiliated clinicians and researchers as advisors and design partners. Each adds credibility and slows competitive entry.

Today: Advisory network at pre-recruit stage. MSCP-credentialed routing graph design is documented; the partnership-with-The-Menopause-Society path is explicit.

Menopause Society brief →
Wired in prototype

Guideline grounding library

A curated, structured, retrievable corpus of menopause guidelines maintained as evidence evolves. The work of building and maintaining it is more durable than the AI models themselves.

Today: Live in the prototype: NAMS / Menopause Society + ACOG + IMS + AACE position statements are wired into the federated grounding store, and every Care Router decision cites the corpus (verifiable on /demo/intake and /demo/agent-fabric). Continuous-update pipeline as evidence evolves is Phase 2 work.

Data inventory brief →
Wired in prototype

Sanction-filtered, menopause-scored provider graph

Vendor provider graphs (Definitive Healthcare, IQVIA OneKey, etc.) are excellent for general healthcare but don't score for menopause and don't run a build-time sanction filter against state license registries. Pause's directory unions CMS NPPES + The Menopause Society MSCP overlay + multi-state license-sanction overlays + Census ZCTA centroids for distance ranking. Each refresh recompounds the moat without requiring a paid feed.

Today: Live today (see /provider). 2,015 menopause-relevant providers across all 50 states + DC / 930 ZIP-3 prefixes (a coverage-aware selection spreads the non-certified budget across prefixes; non-US/garbage postals are gated out). Three state license-sanction overlays at build time (CA Medi-Cal, NY OPMC, TX TMB) — 1,720 sanctioned candidates dropped in the June 2026 build, verifiable per response under provenance.dataset.sanctionedFilteredBySource. The Care Router consumes the same query function the agent and /provider use, so triage and the directory stay in lockstep. National coverage via a paid multi-state license-status feed (Verisys, ProviderTrust) is the Phase-3 hardening path.

Provider graph brief →
Future

Brand and category leadership

Owning 'menopause AI for providers' as a category. First in market, loudest voice in clinical conferences, deepest evidence base.

Today: Pre-market. The investor brief, the demo, and the architecture-honesty posture (LIVE / MOCKED tagging across the deck) are the early proof points.

Operating principles

Read deeper

Where each pillar comes from in the architecture